Abstract
The ADAMs belong to the Adamalysin family of zinc-dependent metalloproteinases. Some ADAMs, as membrane-bound enzymes, are responsible for the ectodomain shedding of transmembrane proteins such as growth factors, the tumor necrosis factor, cytokines and their receptors, signaling molecules, adhesion proteins, and stress molecules involved in immunity. These activities contribute to regulate several physiological and pathological processes including inflammation, cancer, and neurodegenerative diseases. For these reasons, some ADAMs are currently investigated as drug targets to develop new alternative therapies in many fields of medicine. In this chapter, we focus our attention on the most studied ADAMs, that is, ADAM8, ADAM10, and ADAM17 and describe the most innovative ADAM inhibitors developed in the past 10years, taking in consideration synthetic small molecules, natural compounds, and peptide-based inhibitors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
